The same event arrives through several channels and many reports come in incomplete, so teams waste effort on duplicates and chasing missing details.
Adverse-event reports reach safety teams through many channels — call centers, portals, partners, patient programs — and the same event is often reported more than once, in different formats and at different times. Combined with incomplete or ambiguous incoming information, this means effort is wasted merging duplicates and following up for missing details, and undetected duplicates can distort the safety picture. AI approaches help detect probable duplicates and assess incoming data quality so teams can consolidate cases and target follow-up where it counts.
How AI helps with duplicate detection and data quality at intake
Duplicate detection is harder than matching identical records: the same event can arrive with different wording, partial identifiers, and conflicting dates across channels. AI approaches compare incoming reports against existing cases using the combination of fields that characterize a case — product, event, patient descriptors, dates, reporter — and estimate the probability that two reports describe the same occurrence, surfacing likely matches for a person to confirm or merge. In parallel, data-quality checks can flag missing required fields, internal inconsistencies, and reports too thin to process, so gaps are caught at intake rather than deep in the queue. The purpose is to reduce wasted rework and keep the safety database clean, not to merge or discard cases automatically. The tool proposes matches and flags quality issues; a qualified case processor decides whether reports are truly duplicates, what to consolidate, and what follow-up to pursue, and stays accountable for case integrity.
What to evaluate before buying duplicate-detection AI
The core trade-off is between catching real duplicates and wrongly merging distinct cases, and both errors have consequences — missed duplicates distort the safety picture while incorrect merges lose information — so probe how a tool scores match confidence, how it presents candidates for review, and whether it ever merges without a human confirming. Ask how it performs when identifiers are sparse or conflicting, which is exactly when duplicate detection is hardest and most valuable. For data-quality checks, examine which rules are built in, whether they reflect your required fields and conventions, and whether they can be configured. As with any regulated safety tool, review validation, audit trails, and how merge and quality decisions are documented, and confirm it fits your safety database and intake workflow rather than running beside it.
How teams typically get started
A low-risk entry point is running duplicate detection retrospectively against a period of cases whose duplicates the team has already resolved, then comparing the tool's proposed matches against the known answer. That measures how many real duplicates it catches, how often it flags false matches, and how well its confidence scoring guides review — all before it touches live intake. Keeping every proposed merge under human confirmation during the trial keeps case integrity protected.
AI Use Cases That Address This Problem
Case Processing Automation
Frequently asked questions
Why do duplicate and low-quality case reports happen?
The same adverse event is often reported through more than one channel — a patient, a physician, a call center, a partner — in different formats and at different times, and many reports arrive incomplete or ambiguous. The result is duplicated effort, follow-up to fill gaps, and a risk that undetected duplicates distort the overall safety picture.
How does AI detect duplicate case reports?
It compares incoming reports against existing cases using the combination of fields that characterize a case — product, event, patient descriptors, dates, and reporter — and estimates the probability that two reports describe the same event, surfacing likely matches for review. A case processor confirms whether reports are genuine duplicates and decides what to merge.
Will the tool merge or discard cases automatically?
It should not. Because wrongly merging distinct cases loses safety information and missing a duplicate distorts the data, matching and quality flags are best treated as decision support that a qualified person confirms. Look for tools that score confidence and present candidates for review rather than consolidating cases on their own.
What should we ask a duplicate-detection vendor?
Ask how the tool scores match confidence and performs when identifiers are sparse or conflicting, whether it ever merges without human confirmation, which data-quality checks are built in and whether they are configurable to your fields, and how validation, audit trails, and merge decisions are documented within your safety database workflow.
U.S. FDA went live with FAERS II adverse-event reporting powered by LifeSphere MultiVigilance
ArisGlobal announced the go-live of the U.S. FDA's Adverse Event Reporting System (FAERS II), an electronic safety-reporting platform powered by its LifeSphere MultiVigilance software — the federal drug-safety regulator running adverse-event intake on ArisGlobal technology as part of the FDA's technology modernization efforts.